Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations

Felix Bongomin^{1

2}, Nelesh P Govender^{3

4}, Arunaloke Chakrabarti⁵, Florence Robert-Gangneux⁶, David R Boulware⁷, Afia Zafar⁸, Rita O Oladele⁹, Malcolm D Richardson^{10

11}, Jean-Pierre Gangneux⁶, Ana Alastruey-Izquierdo¹², Joel Bazira¹³, Tom H Boyles⁴, Jahit Sarcarlal¹⁴, Mathieu Nacher¹⁵, Taminori Obayashi¹⁶, William Worodria¹⁷, Alessandro C Pasqualotto¹⁸, David B Meya^{17

19}, Ben Cheng²⁰, Charlotte Sriruttan³, Conrad Muzoora¹³, Andrew Kambugu^{17

19}, Juan Luis Rodriguez Tudela¹, Alexander Jordan²¹, Tom M Chiller²¹, David W Denning^{22

23}

Affiliations

¹ Global Action Fund for Fungal Infections, Rue Le Corbusier 12, 1208, Geneva, Switzerland.
² Department of Medical Microbiology and Immunology, Gulu University, Gulu, Uganda.
³ National Institute for Communicable Diseases (Centers for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), Johannesburg, South Africa.
⁴ University of the Witwatersrand, Johannesburg, South Africa.
⁵ Postgraduate Institute of Medical Education and Research, Chandigarh, India.
⁶ Université Rennes et Centre Hospitalier Universitaire de Rennes, Rennes, France.
⁷ University of Minnesota, Minneapolis, USA.
⁸ Aga Khan University, Karachi, Pakistan.
⁹ University of Lagos, Lagos, Nigeria.
¹⁰ The University of Manchester, Manchester, UK.
¹¹ Mycology Reference Centre, Manchester, UK.
¹² Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
¹³ Mbarara University of Science and Technology, Mbarara, Uganda.
¹⁴ Department of Microbiology, Faculty of Medicine , University Eduardo Mondlane, Maputo, Mozambique.
¹⁵ The University of French Guiana, Cayenne, French Guiana.
¹⁶ Higashi Saitama General Hospital, Saitama, Japan.
¹⁷ College of Health Sciences, Makerere University, Kampala, Uganda.
¹⁸ Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
¹⁹ Infectious Disease Institute, Makerere University, Kampala, Uganda.
²⁰ Global Health Impact Group, Atlanta, USA.
²¹ Centers for Disease Control and Prevention, Atlanta, USA.
²² Global Action Fund for Fungal Infections, Rue Le Corbusier 12, 1208, Geneva, Switzerland. ddenning@gaffi.org.
²³ The University of Manchester, Manchester, UK. ddenning@gaffi.org.

PMID: 31175479
DOI: 10.1007/s10096-019-03600-4

Editorial

Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations

Felix Bongomin et al. Eur J Clin Microbiol Infect Dis. 2019 Sep.

. 2019 Sep;38(9):1581-1584.

doi: 10.1007/s10096-019-03600-4.

Authors

Affiliations

¹ Global Action Fund for Fungal Infections, Rue Le Corbusier 12, 1208, Geneva, Switzerland.
² Department of Medical Microbiology and Immunology, Gulu University, Gulu, Uganda.
³ National Institute for Communicable Diseases (Centers for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), Johannesburg, South Africa.
⁴ University of the Witwatersrand, Johannesburg, South Africa.
⁵ Postgraduate Institute of Medical Education and Research, Chandigarh, India.
⁶ Université Rennes et Centre Hospitalier Universitaire de Rennes, Rennes, France.
⁷ University of Minnesota, Minneapolis, USA.
⁸ Aga Khan University, Karachi, Pakistan.
⁹ University of Lagos, Lagos, Nigeria.
¹⁰ The University of Manchester, Manchester, UK.
¹¹ Mycology Reference Centre, Manchester, UK.
¹² Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
¹³ Mbarara University of Science and Technology, Mbarara, Uganda.
¹⁴ Department of Microbiology, Faculty of Medicine , University Eduardo Mondlane, Maputo, Mozambique.
¹⁵ The University of French Guiana, Cayenne, French Guiana.
¹⁶ Higashi Saitama General Hospital, Saitama, Japan.
¹⁷ College of Health Sciences, Makerere University, Kampala, Uganda.
¹⁸ Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
¹⁹ Infectious Disease Institute, Makerere University, Kampala, Uganda.
²⁰ Global Health Impact Group, Atlanta, USA.
²¹ Centers for Disease Control and Prevention, Atlanta, USA.
²² Global Action Fund for Fungal Infections, Rue Le Corbusier 12, 1208, Geneva, Switzerland. ddenning@gaffi.org.
²³ The University of Manchester, Manchester, UK. ddenning@gaffi.org.

PMID: 31175479
DOI: 10.1007/s10096-019-03600-4

No abstract available

Keywords: Aspergillosis; Cryptococcosis; Flucytosine; HIV; Histoplasmosis; Itraconazole; Pneumocystis; Tuberculosis; Voriconazole.

PubMed Disclaimer

References

1. Nat Rev Microbiol. 2004 Mar;2(3):231-40 - PubMed
1. Lancet Infect Dis. 2014 Mar;14(3):239-49 - PubMed
1. Thorax. 2015 Jul;70(7):613-4 - PubMed
1. N Engl J Med. 2016 Jun 30;374(26):2511-4 - PubMed
1. Emerg Infect Dis. 2017 Feb;23(2):177-183 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

MR/P017622/1/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations

Affiliations

Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations

Authors

Affiliations

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical